Our observations with S100P, where transcripts could only be detected in the cancer cell lines and not in the HPNE control cell line, are also in agreement with many studies that demonstrated the involvement of this S100 in the progression of pancreatic cancer [7,54]. This evidence concerns the gene S100P and familial pancreatic carcinoma.